{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:59:03Z","timestamp":1763765943884},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.nano.2012.05.005","type":"journal-article","created":{"date-parts":[[2012,5,26]],"date-time":"2012-05-26T13:02:10Z","timestamp":1338037330000},"page":"S69-S76","source":"Crossref","is-referenced-by-count":19,"special_numbering":"S1","title":["Nanomedicine for treatment of diabetes in an aging population: state-of-the-art and future developments"],"prefix":"10.1016","volume":"8","author":[{"given":"Silke","family":"Krol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rutledge","family":"Ellis-Behnke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2012.05.005_bb0005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.nano.2011.07.003","article-title":"Nanomedicine in the European Commission policy for nanotechnology","volume":"7","author":"Gabellieri","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2012.05.005_bb0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.nano.2012.05.005_bb0015","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc11-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.nano.2012.05.005_bb0020","doi-asserted-by":"crossref","first-page":"985703","DOI":"10.4061\/2011\/985703","article-title":"Multiple comorbid conditions among middle-aged and elderly hemophilia patients: prevalence estimates and implications for future care","volume":"2011","author":"Khleif","year":"2011","journal-title":"J Aging Res"},{"key":"10.1016\/j.nano.2012.05.005_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.regpep.2007.08.017","article-title":"An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment","volume":"146","author":"Marchetti","year":"2008","journal-title":"Regul Pept"},{"key":"10.1016\/j.nano.2012.05.005_bb0030","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(08)60932-0","article-title":"Type 2 diabetes: pathogenesis and treatment","volume":"371","author":"Stumvoll","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.nano.2012.05.005_bb0035","doi-asserted-by":"crossref","first-page":"289S","DOI":"10.1080\/07315724.2010.10719844","article-title":"Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils","volume":"29","author":"Misra","year":"2010","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.nano.2012.05.005_bb0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.nano.2012.05.005_bb0045","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0002-9343(81)90579-9","article-title":"Insulin secretion in diabetes mellitus","volume":"70","author":"Pfeifer","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.nano.2012.05.005_bb0050","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2337\/db08-1651","article-title":"Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice","volume":"58","author":"Tschen","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.nano.2012.05.005_bb0055","doi-asserted-by":"crossref","first-page":"E1317","DOI":"10.1152\/ajpendo.00082.2006","article-title":"Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP","volume":"291","author":"Meier","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.nano.2012.05.005_bb0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cell.2005.05.027","article-title":"Loss of ARNT\/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes","volume":"122","author":"Gunton","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.nano.2012.05.005_bb0065","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2337\/diabetes.54.3.727","article-title":"Functional and molecular defects of pancreatic islets in human type 2 diabetes","volume":"54","author":"Del Guerra","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.nano.2012.05.005_bb0070","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2337\/diabetes.55.02.06.db04-1575","article-title":"Impaired gene and protein expression of exocytotic soluble N-ethylmaleimide attachment protein receptor complex proteins in pancreatic islets of type 2 diabetic patients","volume":"55","author":"Ostenson","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.nano.2012.05.005_bb0075","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/hmg\/ddm325","article-title":"The diabetes-linked transcription factor Pax-4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1","volume":"17","author":"Brun","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nano.2012.05.005_bb0080","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1172\/JCI30706","article-title":"Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes","volume":"117","author":"Lyssenko","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nano.2012.05.005_bb0085","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1210\/jc.2004-0150","article-title":"Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin","volume":"89","author":"Marchetti","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nano.2012.05.005_bb0090","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1093\/hmg\/ddp178","article-title":"Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function","volume":"18","author":"Shu","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nano.2012.05.005_bb0095","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1021\/pr9006816","article-title":"Apoptotic, regenerative, and immune-related signaling in human islets from type 2 diabetes individuals","volume":"8","author":"Nyblom","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.nano.2012.05.005_bb0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/db06-0734","article-title":"Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets","volume":"56","author":"Ritzel","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.nano.2012.05.005_bb0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000218169","article-title":"MicroRNAs in diabetes: tiny players in big disease","volume":"23","author":"Pandey","year":"2009","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.nano.2012.05.005_bb0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nm0106-36","article-title":"MicroRNAs: \u2018ribo-regulators\u2019 of glucose homeostasis","volume":"12","author":"Gauthier","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2012.05.005_bb0115","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1056\/NEJMcibr060065","article-title":"MicroRNAs as therapeutic targets","volume":"354","author":"Czech","year":"2006","journal-title":"The New Eng J Med"},{"key":"10.1016\/j.nano.2012.05.005_bb0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.trsl.2011.01.009","article-title":"Diabetes mellitus, a microRNA-related disease?","volume":"157","author":"Guay","year":"2011","journal-title":"Transl Res"},{"key":"10.1016\/j.nano.2012.05.005_bb0125","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1248\/bpb.33.1033","article-title":"DNA microarray analysis of whole blood cells and insulin-sensitive tissues reveals the usefulness of blood RNA profiling as a source of markers for predicting type 2 diabetes","volume":"33","author":"Hayashi","year":"2010","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.nano.2012.05.005_bb0130","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nm.2414","article-title":"Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport","volume":"17","author":"Ohtsubo","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2012.05.005_bb0135","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0014-5793(00)02380-2","article-title":"Anti-amyloidogenic activity of tetracyclines: studies in vitro","volume":"487","author":"Forloni","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nano.2012.05.005_bb0140","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1039\/c0nr00551g","article-title":"A novel class of potential prion drugs: preliminary in vitro and in vivo data for multilayer coated gold nanoparticles","volume":"2","author":"Tran","year":"2010","journal-title":"Nanoscale"},{"key":"10.1016\/j.nano.2012.05.005_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0169-409X(98)00075-1","article-title":"Oral insulin delivery","volume":"35","author":"Carino","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2012.05.005_bb0150","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.addr.2007.08.019","article-title":"Current challenges in non-invasive insulin delivery systems: a comparative review","volume":"59","author":"Khafagy el-S","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2012.05.005_bb0155","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1586\/erd.09.43","article-title":"Challenges and advances in nanoparticle-based oral insulin delivery","volume":"6","author":"Ramesan","year":"2009","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.nano.2012.05.005_bb0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2010.07.002","article-title":"Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats","volume":"76","author":"Sharma","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2012.05.005_bb0165","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejps.2010.12.007","article-title":"Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery","volume":"42","author":"Makhlof","year":"2011","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2012.05.005_bb0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejpb.2010.09.016","article-title":"Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin","volume":"77","author":"Zhang","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2012.05.005_bb0175","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1208\/s12249-011-9647-5","article-title":"Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin","volume":"12","author":"Elsayed","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.nano.2012.05.005_bb0180","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11095-007-9257-9","article-title":"Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin","volume":"24","author":"Bhumkar","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2012.05.005_bb0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1208\/s12249-010-9561-2","article-title":"Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents","volume":"12","author":"Chaudhury","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.nano.2012.05.005_bb0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/187221109787158346","article-title":"Chitosan and its use in design of insulin delivery system","volume":"3","author":"Wong","year":"2009","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"10.1016\/j.nano.2012.05.005_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2011.08.087","article-title":"A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery","author":"Chen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2012.05.005_bb0200","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2012.05.005_bb0205","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrmicro1840","article-title":"Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria","volume":"6","author":"Wells","year":"2008","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"10.1016\/j.nano.2012.05.005_bb0210","first-page":"1427","article-title":"A case of anaphylaxis caused by the health food chitosan","volume":"54","author":"Kato","year":"2005","journal-title":"Arerugi"},{"key":"10.1016\/j.nano.2012.05.005_bb0215","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.2337\/db08-0331","article-title":"The \u201cperfect storm\u201d for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity","volume":"57","author":"Vaarala","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.nano.2012.05.005_bb0220","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2165\/00003495-198734030-00003","article-title":"Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use","volume":"34","author":"Brogden","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.nano.2012.05.005_bb0225","first-page":"476","article-title":"Gastric mucosal blood flow and blood viscosity in patients with diabetes","volume":"73","author":"Zhu","year":"1993","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.nano.2012.05.005_bb0230","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000212766","article-title":"Ageing and small-bowel mucosa: a morphometric study","volume":"32","author":"Corazza","year":"1986","journal-title":"Gerontology"},{"key":"10.1016\/j.nano.2012.05.005_bb0235","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/BF02388803","article-title":"The thickness of the mucus layer in different segments of the rats intestine","volume":"27","author":"Szentkuti","year":"1995","journal-title":"Histochem J"},{"key":"10.1016\/j.nano.2012.05.005_bb0240","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1073\/pnas.0504978102","article-title":"Obesity alters gut microbial ecology","volume":"102","author":"Ley","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nano.2012.05.005_bb0245","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ejps.2010.08.009","article-title":"Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles","volume":"41","author":"Woitiski","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2012.05.005_bb0250","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jps.21874","article-title":"Poly(epsilon-caprolactone)\/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes","volume":"99","author":"Damg\u00e9","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2012.05.005_bb0255","unstructured":"http:\/\/www.businesswire.com\/portal\/site\/home\/email\/alert\/?ndmViewId=news_view&newsLang=en&newsId=20080409005647."},{"key":"10.1016\/j.nano.2012.05.005_bb0260","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1183\/09031936.00129907","article-title":"Effects of inhaled human insulin on airway lining fluid composition in adults with diabetes","volume":"32","author":"Liu","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.nano.2012.05.005_bb0265","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejpb.2010.12.025","article-title":"The influence of pulmonary surfactant on nanoparticulate drug delivery systems","volume":"77","author":"Schleh","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2012.05.005_bb0270","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1023\/A:1016418523014","article-title":"Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles","volume":"19","author":"Dyer","year":"2002","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2012.05.005_bb0275","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1183\/09031936.05.00002105","article-title":"Long-term clearance from small airways decreases with age","volume":"26","author":"Svartengren","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.nano.2012.05.005_bb0280","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1183\/09031936.99.14614549","article-title":"Physiological changes in respiratory function associated with ageing","volume":"13","author":"Janssens","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.nano.2012.05.005_bb0285","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1464-5491.2005.01499.x","article-title":"Animal models of diabetes mellitus","volume":"22","author":"Rees","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.nano.2012.05.005_bb0290","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/ni0710-558","article-title":"The future of mucosal immunology: studying an integrated system-wide organ","volume":"11","author":"Gill","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.nano.2012.05.005_bb0295","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.addr.2008.09.009","article-title":"Lessons from nature: \u201cPathogen-Mimetic\u201d systems for mucosal nano-medicines","volume":"61","author":"Mrsny","year":"2009","journal-title":"Drug Deliv Rev"},{"key":"10.1016\/j.nano.2012.05.005_bb0300","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2337\/db07-0197","article-title":"High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes","volume":"56","author":"Huang","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.nano.2012.05.005_bb0305","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrg2968","article-title":"Current prospects for RNA interference-based therapies","volume":"12","author":"Davidson","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.nano.2012.05.005_bb0310","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2337\/db06-0269","article-title":"Oral insulin-mimetic compounds that act independently of insulin","volume":"56","author":"Garc\u00eda-Vicente","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.nano.2012.05.005_bb0315","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1002\/jps.22463","article-title":"Phenylboronic acid grafted chitosan as a glucose-sensitive vehicle for controlled insulin release","volume":"100","author":"Wu","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2012.05.005_bb0320","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1021\/nn1008319","article-title":"Multifunctional hybrid nanogel for integration of optical glucose sensing and self-regulated insulin release at physiological pH","volume":"4","author":"Wu","year":"2010","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2012.05.005_bb0325","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/17425247.2011.559458","article-title":"Water-in-oil microemulsions for effective transdermal delivery of proteins","volume":"8","author":"Russell-Jones","year":"2011","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2012.05.005_bb0330","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2010.07.052","article-title":"Sustained prolonged topical delivery of bioactive human insulin for potential treatment of cutaneous wounds","volume":"398","author":"Hrynyk","year":"2010","journal-title":"Int J Pharm"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963412001852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963412001852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:51:21Z","timestamp":1542934281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963412001852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":66,"alternative-id":["S1549963412001852"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2012.05.005","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}